Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

This study examines how executives' IT backgrounds affect corporate digital technology innovation, using panel data from listed companies between 2011 and 2021. Findings indicate that executives' IT backgrounds significantly enhance corporate digital technology innovation, particularly in digital technology invention patents, where the effect is especially pronounced, and the results are robust. Mechanistic analysis suggests managerial myopia and executives' attention to digital technology are key factors that allow executives' IT backgrounds to promote corporate digital technology innovation. Further analysis shows executives' IT backgrounds have a greater promotional effect on digital technology innovation in state-owned enterprises, non-IT sectors, firms with influential executives, and organizations with long-serving executives. Economic analysis reveals that executives' IT backgrounds can improve corporate financial performance by enhancing digital technology innovation. This paper highlights the importance of executive IT human capital and provides insights into government and corporate talent recruitment policies.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12036915PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0320844PLOS

Publication Analysis

Top Keywords

digital technology
32
technology innovation
24
executives' backgrounds
20
corporate digital
16
digital
8
technology
8
executives'
7
corporate
6
innovation
6
backgrounds
5

Similar Publications

Background: With the availability of more advanced and effective treatments, life expectancy has improved among patients with metastatic breast cancer (MBC), but this makes communication with their medical oncologist more complex. Some patients struggle to learn about their therapeutic options and to understand and articulate their preferences. Mobile health (mHealth) apps can enhance patient-provider communication, playing a crucial role in the diagnosis, treatment, quality of life, and outcomes for patients living with MBC.

View Article and Find Full Text PDF

Since the first decentralized clinical trial (DCT) was conducted in 2011, there has been an increased usage of DCT due to its benefits of patient-centricity and generalizability of findings. This trend was further expedited by the global COVID-19 pandemic. We identified 23 case studies across various therapeutic areas and grouped them into different categories according to their purposes-by necessity, for operational benefits, to address unique research questions, to validate innovative digital endpoints, or to validate decentralization as a clinical research platform.

View Article and Find Full Text PDF

Objectives: To evaluate the performance of artificial intelligence (AI)-based models in predicting elevated neonatal insulin levels through fetal hepatic echotexture analysis.

Methods: This diagnostic accuracy study analyzed ultrasound images of fetal livers from pregnancies between 37 and 42 weeks, including cases with and without gestational diabetes mellitus (GDM). Images were stored in Digital Imaging and Communications in Medicine (DICOM) format, annotated by experts, and converted to segmented masks after quality checks.

View Article and Find Full Text PDF

IntroductionThe use of digital solutions including patient-reported outcomes is limited to follow-up of patients with established diagnoses but is rarely used as first step of the diagnostic process substituting a personal contact with a health professional. We report on the diagnostic validity and cost per patient implications based on a feasibility study of a new virtual diagnostic service (VDS) for common neurological sleep disorders that, as a first step, involves the collection and automated analysis of self-reported digital patient data.MethodsThe VDS was established at the Odense University Hospital, Denmark.

View Article and Find Full Text PDF

Methods to Validate Digital Health Technologies for Dermatology.

J Invest Dermatol

September 2025

Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA; Sibel Health, Chicago, Illinois, USA; Querrey Simpson Institute for Bioelectronics, Northwestern University, Evanston, Illinois, USA. Electronic address:

The integration of wearable medical devices and digital health technologies (DHTs) in health care has grown significantly during the past 2 decades, particularly in dermatology, in which objective measurement of symptoms such as itch remains challenging. This review examines the evolution of DHTs in dermatology, focusing on the validation frameworks necessary for their implementation in clinical trials and research. We discuss the key stages of validation: hardware validation to ensure device reliability, analytical validation to transform raw sensor data into meaningful metrics, and clinical validation to demonstrate utility in specific patient populations.

View Article and Find Full Text PDF